How It Works

How It Works

A novel dual
mechanism of
action.

Contact Us

Contact Us

Contact a Baxter rep in your area.

HEMOPATCH Advantage

Firm Adherence to the Tissue Surface

  • NHS-PEG provides firm tissue attachment1

Designed for Utmost Flexibility

  • Soft, thin, flexible, collagen pad gives you easy control during application1

Fast and Effective Hemostasis

  • Three-dimensional structure provides mechanical strengthening of the clot1
  • 98% hemostatic success at 2 minutes was demonstrated in a preclinical model2
  • HEMOPATCH provides greater hemostatic success faster and more sustained than the comparator fibrin sealant patch3

Ready to Use

  • No preparation required, room temperature storage*

Distinctive Blue Dot Pattern

  • To quickly differentiate the non-coated side

HEMOPATCH Advantage

When in contact with blood, the tissue-adhering properties of HEMOPATCH are enhanced to seal the bleeding surface.

Indication for Use

HEMOPATCH Sealing Hemostat is intended as a hemostatic device for surgical procedures when control of bleeding by pressure, ligature, or conventional procedures is either ineffective or impractical.

References

  1. HEMOPATCH Sealing Hemostat Instructions for Use. Zürich, Switzerland: Baxter Healthcare SA; 2014.
  2. Lewis KM, Hedrich HC, Regenbogen J, Schiviz A, Gulle H, Goppelt A. Hemostatic efficacy of a novel, PEG-coated collagen patch (HEMOPATCH) versus oxidized cellulose (SURGICEL®/Tabotamp™) in a porcine hepatic and leporine vascular surgical model. Poster presented at: Jahrestagung der Vereinigung Mittelrheinischer Chirurgen; Tübingen, Germany; 26-27 September.
  3. Lewis KM, Hedrich HC, Regenbogen J, Schiviz A, Gulle H, Goppelt A. Hemostatic efficacy of a novel, PEG-coated collagen patch (HEMOPATCH) versus a fibrinogen-coated collagen patch (TachoSil) in a porcine and leporine hepatic surgical model. Poster presented at: Jahrestagung der Vereinigung Mittelrheinischer Chirurgen; Tübingen, Germany; 26-27 September.

* for 6 months within the shelf life